Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
about
Safety and efficacy of peramivir for influenza treatmentProlonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferretsResistance mutation R292K is induced in influenza A(H6N2) virus by exposure of infected mallards to low levels of oseltamivirAntivirals in the 2009 pandemic--lessons and implications for future strategies.Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan.Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic.Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital.Antiviral treatment among older adults hospitalized with influenza, 2006-2012The US Influenza Hospitalization Surveillance NetworkIncreased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in CaliforniaImpact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010Impact of medical and behavioural factors on influenza-like illness, healthcare-seeking, and antiviral treatment during the 2009 H1N1 pandemic: USA, 2009-2010.Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired PneumoniaUse of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza seasonInfluenza antiviral treatment in spinal cord injury patients, 2007-2010Survey of influenza and other respiratory viruses diagnostic testing in US hospitals, 2012-2013Optimizing antiviral therapy for influenza: understanding the evidence.Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model.Benefit of Early Initiation of Influenza Antiviral Treatment to Pregnant Women Hospitalized With Laboratory-Confirmed Influenza.A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility--North Carolina and South Carolina, 2010-2011.Patients hospitalized with laboratory-confirmed influenza during the 2010-2011 influenza season: exploring disease severity by virus type and subtype.Editorial commentary. "Late" treatment with neuraminidase inhibitors for severely ill patients with influenza: better late than never?
P2860
Q27027408-58DDF219-993C-42A7-B298-6B2F78AE9B29Q27334946-43B701FD-CC0E-43C4-968E-C25225CE78EFQ28535274-D3303885-C45F-438A-B5DE-DCC6D8C62632Q30219151-E40B594E-98A2-4F04-A946-7948929F142EQ30352057-499E971C-2159-473F-A362-BEC7A17F0C14Q30357688-CB66C72F-0AD6-4C02-AC95-0AD10FD57082Q30358632-0A75B6AB-7E43-4BF9-8AEF-31A10ADC5BEFQ30373020-52F23032-17C1-4DD2-9DAE-D92A5CF6DC31Q30378144-2A37067A-CDEE-445A-87D3-798C40B874F4Q30396792-20AB8B28-539A-4149-9B5D-678914F83D93Q30412191-DB96F237-5EF7-49D7-AD07-4C15E2AB6A34Q30415719-3802F588-3CA6-495D-8952-7EEEC9299EACQ30419774-7C66FEC9-BC01-4838-81D4-32A64786C1CCQ30428627-E71A8B1E-EB1C-4B13-BC8E-B19495D5BCFBQ33629039-9661616B-2FC0-4CB0-8496-FD8FE76FDD32Q34354261-E924DEB2-A84E-439F-9B55-A2C82F5E33E2Q34947758-792B72AC-317B-4E43-ABBC-842C0127A2E5Q38299002-A824A62A-91DC-4E5F-ADBD-2DA24325FF49Q38361244-50804ABB-BEF4-4B71-B874-0C400DF9E696Q40083222-092E883B-5F6B-4D26-A5BB-A96D559E8160Q40779930-6D8D1BF8-5D66-47CB-B2FD-2E1D7600AFFDQ42282531-0E80695D-DDA6-4E3B-B136-10DCEFCE3E6DQ42283189-1D1D41A8-2935-42DE-BBC8-BE08655ED32CQ43865089-5A1E3762-D740-45D5-86B4-08FD49CCF331
P2860
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Description of antiviral treat ...... mic: United States, 2005-2009.
@ast
Description of antiviral treat ...... mic: United States, 2005-2009.
@en
type
label
Description of antiviral treat ...... mic: United States, 2005-2009.
@ast
Description of antiviral treat ...... mic: United States, 2005-2009.
@en
prefLabel
Description of antiviral treat ...... mic: United States, 2005-2009.
@ast
Description of antiviral treat ...... mic: United States, 2005-2009.
@en
P2093
P50
P356
P1476
Description of antiviral treat ...... mic: United States, 2005-2009.
@en
P2093
Alejandro Perez
Ann Thomas
Arthur Reingold
Craig Morin
Emily B Hancock
Joan Baumbach
Kathryn Arnold
Ken Gershman
Laurie Kamimoto
Nancy M Bennett
P304
P356
10.1093/INFDIS/JIR648
P407
P577
2011-10-19T00:00:00Z